Do Not Do Recommendation

 
For patients who are receiving treatment with trastuzumab for advanced breast cancer, discontinue treatment with trastuzumab at the time of disease progression outside the central nervous system. Do not discontinue trastuzumab if disease progression is within the central nervous system alone.

Do Not Do Recommendation Details

Recommendation:
For patients who are receiving treatment with trastuzumab for advanced breast cancer, discontinue treatment with trastuzumab at the time of disease progression outside the central nervous system. Do not discontinue trastuzumab if disease progression is within the central nervous system alone.
Interventions:
trastuzumab

Source guidance details

Guidance:
Adavnced breast cancer (update) (CG81)
Published date:
July 2014
Paragraph number:
1.3.12
Page number:
12

View all NICE do not do from this Guidance